IBM, Shares

IBM Shares Gain Momentum as Analysts Revise Outlooks

17.01.2026 - 11:45:04

IBM US4592001014

IBM approaches its fourth-quarter earnings report with significant positive momentum. The company's stock has demonstrated a clear upward trajectory in recent weeks, coinciding with a steady stream of analyst upgrades. Key drivers behind this optimism include revised free cash flow projections, the planned acquisition of Confluent, and new software offerings focused on artificial intelligence and data sovereignty.

A major strategic development is the planned $11 billion acquisition of Confluent, which recently passed a critical antitrust review by U.S. regulators. This clearance substantially reduces the execution risk of the transaction. Confluent specializes in data-streaming technology, and its integration is intended to bolster IBM's capabilities in enterprise AI and real-time data processing. The long-term goal is to construct a "Smart Data Platform" to support secure, large-scale generative AI workloads for corporate clients.

Revised Price Targets Reflect Confidence

Sentiment on Wall Street has noticeably improved. In a prominent move, Bank of America analyst Wamsi Mohan raised his price target for IBM from $315 to $335 per share, reiterating a "Buy" rating. This valuation is based on an estimated enterprise-value-to-free-cash-flow (EV/FCF) multiple of 23 for 2027, which sits above the stock's historical range of 8 to 22 (median 13). Mohan justifies this premium by citing enhanced growth prospects and free cash flow dynamics, largely attributed to the Red Hat business.

Key projections from Bank of America include:
- 2025 Free Cash Flow: approximately $14.0 billion
- Expected 2026 FCF Guidance: about $15 billion
- Net Income to Free Cash Flow Ratio: 130%
- Slightly raised 2025 Revenue Estimate: from $66.9 billion to $67.1 billion

The recent stock performance supports this brighter picture. Shares closed at $305.67 last Friday, marking a daily gain of 2.59%. Over a twelve-month period, the stock is up over 41% and trades just over 2% below its recent 52-week high.

Near-Term Margin Pressure from Restructuring

Analysts, however, anticipate some near-term headwinds for profitability margins. This is due to "workforce rebalancing" initiatives being implemented in the current fourth quarter. Bank of America estimates these restructuring efforts will incur a cost of roughly $400 million in Q4. Consequently, while the pre-tax income margin for the full year 2025 is still expected to improve, the increase may be more modest than initially guided. The bank now forecasts an annual gain of approximately 70 basis points, down from an earlier expectation of more than 100 basis points.

Should investors sell immediately? Or is it worth buying IBM?

This paints a clear picture: restructuring costs will pressure results in the short term, with the benefits to profitability expected to materialize over the medium term.

Solid Quarterly Foundation and Technical Strength

Fundamentally, IBM enters this period from a position of strength, building on a solid previous quarter. Earnings per share came in at $2.65, surpassing market expectations of $2.45. Revenue reached $16.33 billion, representing a year-over-year increase of 9.1%.

The technical chart analysis further underscores the current bullish trend. The stock has risen over 18% on a 30-day view and is up nearly 5% since the start of 2026. It currently trades about 10% above its 50-day moving average and more than 24% above its 200-day moving average. A Relative Strength Index (RSI) reading of 66.6 indicates strong, though not yet extreme, upward momentum.

Launch of Sovereign Data Software

In parallel, IBM is advancing its software strategy. On January 15, the company introduced "IBM Sovereign Core," a sovereignty-ready, AI-capable software platform designed for enterprises, government agencies, and service providers. This addresses growing demands for digital sovereignty, allowing organizations to run AI workloads in self-managed environments while maintaining full operational control. The platform is specifically tailored for regulated and security-critical use cases.

Forthcoming Earnings as the Next Catalyst

All eyes are now on IBM's fourth-quarter 2025 results, scheduled for release on January 28, which will include guidance for 2026. Analysts anticipate signs of more stable demand in the enterprise client segment. Goldman Sachs suggests the outlook for 2026 could brighten, given the discussed growth drivers and the strong recent performance in both share price and earnings.

The critical test will be whether IBM can consolidate the high expectations around free cash flow, margin improvement, and AI-driven growth initiatives into a coherent forecast. Success in doing so would provide fundamental support for the recent rally in its share price.

Ad

IBM Stock: Buy or Sell?! New IBM Analysis from January 17 delivers the answer:

The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 17.

IBM: Buy or sell? Read more here...

@ boerse-global.de | US4592001014 IBM